Global Immunoprecipitation Market 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	161 Pages	TechNavio	March, 2024	INF18655851

Best Price Guarantee
Price	from $2,500
Length	161 Pages
Publisher	TechNavio
Published Date	March, 2024
SKU	INF18655851

Global Immunoprecipitation Market 2024-2028

The immunoprecipitation market is forecasted to grow by USD 270.1 mn during 2023-2028, accelerating at a CAGR of 6.01% during the forecast period. The report on the immunoprecipitation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing r and d in biopharmaceuticals, rising demand for therapeutic antibodies, and growing focus on newborn screening tests.

Technavio's immunoprecipitation market is segmented as below:

By End-user

Academic and research institutes
Contract research organizations
Pharmaceutical and biotechnology companies

By Type

Chromatin immunoprecipitation
Individual protein immunoprecipitation
Co-immunoprecipitation
RNA immunoprecipitation

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the rising number of genome projects as one of the prime reasons driving the immunoprecipitation market growth during the next few years. Also, increasing clinical trials and growing expansion of contract manufacturing organizations and cros will lead to sizable demand in the market.

The report on the immunoprecipitation market covers the following areas:

Immunoprecipitation market sizing
Immunoprecipitation market forecast
Immunoprecipitation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading immunoprecipitation market vendors that include Active Motif Inc., Agilent Technologies Inc., Becton Dickinson and Company, Bio Rad Laboratories Inc., Cell Signaling Technology Inc., Chargen Life Sciences LLP, CLOUD CLONE CORP., Creative Biolabs, Danaher Corp., GenScript Biotech Corp., JSR Micro Inc., Merck KGaA, OriGene Technologies Inc., PerkinElmer Inc, Proteintech Group Inc., Rockland Immunochemicals Inc., Santa Cruz Biotechnology Inc., Sino Biological Inc., and Thermo Fisher Scientific Inc.. Also, the immunoprecipitation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Global Market Characteristics; Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary - Chart on Market Segmentation by Type; Exhibit 07: Executive Summary - Chart on Incremental Growth; Exhibit 08: Executive Summary - Data Table on Incremental Growth; Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Global immunoprecipitation market 2018 - 2022; Exhibit 18: Historic Market Size - Data Table on global immunoprecipitation market 2018 - 2022 ($ million); 4.2 End-User Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - End-User Segment 2018 - 2022 ($ million); 4.3 Type Segment Analysis 2018 - 2022; Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ million); 4.4 Geography Segment Analysis 2018 - 2022; Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); 4.5 Country Segment Analysis 2018 - 2022; Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 23: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 30: Chart on End-user - Market share 2023-2028 (%); Exhibit 31: Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Exhibit 32: Chart on Comparison by End-user; Exhibit 33: Data Table on Comparison by End-user; 6.3 Academic and research institutes - Market size and forecast 2023-2028; Exhibit 34: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibit 35: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibit 36: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibit 37: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%); 6.4 Contract research organizations - Market size and forecast 2023-2028; Exhibit 38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million); Exhibit 39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million); Exhibit 40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%); Exhibit 41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%); 6.5 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028; Exhibit 42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibit 43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibit 44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibit 45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); 6.6 Market opportunity by End-user; Exhibit 46: Market opportunity by End-user ($ million); Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Type: 7.1 Market segments; Exhibit 48: Chart on Type - Market share 2023-2028 (%); Exhibit 49: Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Exhibit 50: Chart on Comparison by Type; Exhibit 51: Data Table on Comparison by Type; 7.3 Chromatin immunoprecipitation - Market size and forecast 2023-2028; Exhibit 52: Chart on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 53: Data Table on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 54: Chart on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibit 55: Data Table on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%); 7.4 Individual protein immunoprecipitation - Market size and forecast 2023-2028; Exhibit 56: Chart on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 57: Data Table on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 58: Chart on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibit 59: Data Table on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%); 7.5 Co-immunoprecipitation - Market size and forecast 2023-2028; Exhibit 60: Chart on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 61: Data Table on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 62: Chart on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibit 63: Data Table on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%); 7.6 RNA immunoprecipitation - Market size and forecast 2023-2028; Exhibit 64: Chart on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 65: Data Table on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibit 66: Chart on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibit 67: Data Table on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%); 7.7 Market opportunity by Type; Exhibit 68: Market opportunity by Type ($ million); Exhibit 69: Data Table on Market opportunity by Type ($ million)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape: 9.1 Geographic segmentation; Exhibit 71: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibit 72: Data Table on Market share By Geographical Landscape 2023-2028 (%); 9.2 Geographic comparison; Exhibit 73: Chart on Geographic comparison; Exhibit 74: Data Table on Geographic comparison; 9.3 North America - Market size and forecast 2023-2028; Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%); 9.4 Europe - Market size and forecast 2023-2028; Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%); 9.5 Asia - Market size and forecast 2023-2028; Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%); 9.6 Rest of World (ROW) - Market size and forecast 2023-2028; Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); 9.7 US - Market size and forecast 2023-2028; Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%); 9.8 UK - Market size and forecast 2023-2028; Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%); 9.9 China - Market size and forecast 2023-2028; Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%); Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%); 9.10 Germany - Market size and forecast 2023-2028; Exhibit 103: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 104: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibit 105: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibit 106: Data Table on Germany - Year-over-year growth 2023-2028 (%); 9.11 Canada - Market size and forecast 2023-2028; Exhibit 107: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 108: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibit 109: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibit 110: Data Table on Canada - Year-over-year growth 2023-2028 (%); 9.12 Market opportunity By Geographical Landscape; Exhibit 111: Market opportunity By Geographical Landscape ($ million); Exhibit 112: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 113: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 114: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 115: Overview on factors of disruption; 11.4 Industry risks; Exhibit 116: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 117: Vendors covered; 12.2 Market positioning of vendors; Exhibit 118: Matrix on vendor position and classification; 12.3 Active Motif Inc.; Exhibit 119: Active Motif Inc. - Overview; Exhibit 120: Active Motif Inc. - Product / Service; Exhibit 121: Active Motif Inc. - Key offerings; 12.4 Agilent Technologies Inc.; Exhibit 122: Agilent Technologies Inc. - Overview; Exhibit 123: Agilent Technologies Inc. - Business segments; Exhibit 124: Agilent Technologies Inc. - Key news; Exhibit 125: Agilent Technologies Inc. - Key offerings; Exhibit 126: Agilent Technologies Inc. - Segment focus; 12.5 Becton Dickinson and Company; Exhibit 127: Becton Dickinson and Company - Overview; Exhibit 128: Becton Dickinson and Company - Business segments; Exhibit 129: Becton Dickinson and Company - Key news; Exhibit 130: Becton Dickinson and Company - Key offerings; Exhibit 131: Becton Dickinson and Company - Segment focus; 12.6 Bio Rad Laboratories Inc.; Exhibit 132: Bio Rad Laboratories Inc. - Overview; Exhibit 133: Bio Rad Laboratories Inc. - Business segments; Exhibit 134: Bio Rad Laboratories Inc. - Key news; Exhibit 135: Bio Rad Laboratories Inc. - Key offerings; Exhibit 136: Bio Rad Laboratories Inc. - Segment focus; 12.7 Cell Signaling Technology Inc.; Exhibit 137: Cell Signaling Technology Inc. - Overview; Exhibit 138: Cell Signaling Technology Inc. - Product / Service; Exhibit 139: Cell Signaling Technology Inc. - Key offerings; 12.8 Danaher Corp.; Exhibit 140: Danaher Corp. - Overview; Exhibit 141: Danaher Corp. - Business segments; Exhibit 142: Danaher Corp. - Key news; Exhibit 143: Danaher Corp. - Key offerings; Exhibit 144: Danaher Corp. - Segment focus; 12.9 GenScript Biotech Corp.; Exhibit 145: GenScript Biotech Corp. - Overview; Exhibit 146: GenScript Biotech Corp. - Business segments; Exhibit 147: GenScript Biotech Corp. - Key news; Exhibit 148: GenScript Biotech Corp. - Key offerings; Exhibit 149: GenScript Biotech Corp. - Segment focus; 12.10 JSR Micro Inc.; Exhibit 150: JSR Micro Inc. - Overview; Exhibit 151: JSR Micro Inc. - Product / Service; Exhibit 152: JSR Micro Inc. - Key offerings; 12.11 Merck KGaA; Exhibit 153: Merck KGaA - Overview; Exhibit 154: Merck KGaA - Business segments; Exhibit 155: Merck KGaA - Key news; Exhibit 156: Merck KGaA - Key offerings; Exhibit 157: Merck KGaA - Segment focus; 12.12 OriGene Technologies Inc.; Exhibit 158: OriGene Technologies Inc. - Overview; Exhibit 159: OriGene Technologies Inc. - Product / Service; Exhibit 160: OriGene Technologies Inc. - Key offerings; 12.13 PerkinElmer Inc; Exhibit 161: PerkinElmer Inc - Overview; Exhibit 162: PerkinElmer Inc - Business segments; Exhibit 163: PerkinElmer Inc - Key news; Exhibit 164: PerkinElmer Inc - Key offerings; Exhibit 165: PerkinElmer Inc - Segment focus; 12.14 Proteintech Group Inc.; Exhibit 166: Proteintech Group Inc. - Overview; Exhibit 167: Proteintech Group Inc. - Product / Service; Exhibit 168: Proteintech Group Inc. - Key offerings; 12.15 Rockland Immunochemicals Inc.; Exhibit 169: Rockland Immunochemicals Inc. - Overview; Exhibit 170: Rockland Immunochemicals Inc. - Product / Service; Exhibit 171: Rockland Immunochemicals Inc. - Key offerings; 12.16 Santa Cruz Biotechnology Inc.; Exhibit 172: Santa Cruz Biotechnology Inc. - Overview; Exhibit 173: Santa Cruz Biotechnology Inc. - Product / Service; Exhibit 174: Santa Cruz Biotechnology Inc. - Key offerings; 12.17 Thermo Fisher Scientific Inc.; Exhibit 175: Thermo Fisher Scientific Inc. - Overview; Exhibit 176: Thermo Fisher Scientific Inc. - Business segments; Exhibit 177: Thermo Fisher Scientific Inc. - Key news; Exhibit 178: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 179: Thermo Fisher Scientific Inc. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 180: Inclusions checklist; Exhibit 181: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 182: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 183: Research methodology; Exhibit 184: Validation techniques employed for market sizing; Exhibit 185: Information sources; 13.5 List of abbreviations; Exhibit 186: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by End-user; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million); Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million); Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%); Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%); Exhibits18: Historic Market Size - Data Table on global immunoprecipitation market 2018 - 2022 ($ million); Exhibits19: Historic Market Size - End-User Segment 2018 - 2022 ($ million); Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million); Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million); Exhibits23: Five forces analysis - Comparison between 2023 and 2028; Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits29: Chart on Market condition - Five forces 2023 and 2028; Exhibits30: Chart on End-user - Market share 2023-2028 (%); Exhibits31: Data Table on End-user - Market share 2023-2028 (%); Exhibits32: Chart on Comparison by End-user; Exhibits33: Data Table on Comparison by End-user; Exhibits34: Chart on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits35: Data Table on Academic and research institutes - Market size and forecast 2023-2028 ($ million); Exhibits36: Chart on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibits37: Data Table on Academic and research institutes - Year-over-year growth 2023-2028 (%); Exhibits38: Chart on Contract research organizations - Market size and forecast 2023-2028 ($ million); Exhibits39: Data Table on Contract research organizations - Market size and forecast 2023-2028 ($ million); Exhibits40: Chart on Contract research organizations - Year-over-year growth 2023-2028 (%); Exhibits41: Data Table on Contract research organizations - Year-over-year growth 2023-2028 (%); Exhibits42: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits43: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million); Exhibits44: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits45: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%); Exhibits46: Market opportunity by End-user ($ million); Exhibits47: Data Table on Market opportunity by End-user ($ million); Exhibits48: Chart on Type - Market share 2023-2028 (%); Exhibits49: Data Table on Type - Market share 2023-2028 (%); Exhibits50: Chart on Comparison by Type; Exhibits51: Data Table on Comparison by Type; Exhibits52: Chart on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits53: Data Table on Chromatin immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits54: Chart on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits55: Data Table on Chromatin immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits56: Chart on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits57: Data Table on Individual protein immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits58: Chart on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits59: Data Table on Individual protein immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits60: Chart on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits61: Data Table on Co-immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits62: Chart on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits63: Data Table on Co-immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits64: Chart on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits65: Data Table on RNA immunoprecipitation - Market size and forecast 2023-2028 ($ million); Exhibits66: Chart on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits67: Data Table on RNA immunoprecipitation - Year-over-year growth 2023-2028 (%); Exhibits68: Market opportunity by Type ($ million); Exhibits69: Data Table on Market opportunity by Type ($ million); Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits71: Chart on Market share By Geographical Landscape 2023-2028 (%); Exhibits72: Data Table on Market share By Geographical Landscape 2023-2028 (%); Exhibits73: Chart on Geographic comparison; Exhibits74: Data Table on Geographic comparison; Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%); Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million); Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million); Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%); Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%); Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million); Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%); Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%); Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%); Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ million); Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ million); Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%); Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%); Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million); Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million); Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%); Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%); Exhibits103: Chart on Germany - Market size and forecast 2023-2028 ($ million); Exhibits104: Data Table on Germany - Market size and forecast 2023-2028 ($ million); Exhibits105: Chart on Germany - Year-over-year growth 2023-2028 (%); Exhibits106: Data Table on Germany - Year-over-year growth 2023-2028 (%); Exhibits107: Chart on Canada - Market size and forecast 2023-2028 ($ million); Exhibits108: Data Table on Canada - Market size and forecast 2023-2028 ($ million); Exhibits109: Chart on Canada - Year-over-year growth 2023-2028 (%); Exhibits110: Data Table on Canada - Year-over-year growth 2023-2028 (%); Exhibits111: Market opportunity By Geographical Landscape ($ million); Exhibits112: Data Tables on Market opportunity By Geographical Landscape ($ million); Exhibits113: Impact of drivers and challenges in 2023 and 2028; Exhibits114: Overview on Criticality of inputs and Factors of differentiation; Exhibits115: Overview on factors of disruption; Exhibits116: Impact of key risks on business; Exhibits117: Vendors covered; Exhibits118: Matrix on vendor position and classification; Exhibits119: Active Motif Inc. - Overview; Exhibits120: Active Motif Inc. - Product / Service; Exhibits121: Active Motif Inc. - Key offerings; Exhibits122: Agilent Technologies Inc. - Overview; Exhibits123: Agilent Technologies Inc. - Business segments; Exhibits124: Agilent Technologies Inc. - Key news; Exhibits125: Agilent Technologies Inc. - Key offerings; Exhibits126: Agilent Technologies Inc. - Segment focus; Exhibits127: Becton Dickinson and Company - Overview; Exhibits128: Becton Dickinson and Company - Business segments; Exhibits129: Becton Dickinson and Company - Key news; Exhibits130: Becton Dickinson and Company - Key offerings; Exhibits131: Becton Dickinson and Company - Segment focus; Exhibits132: Bio Rad Laboratories Inc. - Overview; Exhibits133: Bio Rad Laboratories Inc. - Business segments; Exhibits134: Bio Rad Laboratories Inc. - Key news; Exhibits135: Bio Rad Laboratories Inc. - Key offerings; Exhibits136: Bio Rad Laboratories Inc. - Segment focus; Exhibits137: Cell Signaling Technology Inc. - Overview; Exhibits138: Cell Signaling Technology Inc. - Product / Service; Exhibits139: Cell Signaling Technology Inc. - Key offerings; Exhibits140: Danaher Corp. - Overview; Exhibits141: Danaher Corp. - Business segments; Exhibits142: Danaher Corp. - Key news; Exhibits143: Danaher Corp. - Key offerings; Exhibits144: Danaher Corp. - Segment focus; Exhibits145: GenScript Biotech Corp. - Overview; Exhibits146: GenScript Biotech Corp. - Business segments; Exhibits147: GenScript Biotech Corp. - Key news; Exhibits148: GenScript Biotech Corp. - Key offerings; Exhibits149: GenScript Biotech Corp. - Segment focus; Exhibits150: JSR Micro Inc. - Overview; Exhibits151: JSR Micro Inc. - Product / Service; Exhibits152: JSR Micro Inc. - Key offerings; Exhibits153: Merck KGaA - Overview; Exhibits154: Merck KGaA - Business segments; Exhibits155: Merck KGaA - Key news; Exhibits156: Merck KGaA - Key offerings; Exhibits157: Merck KGaA - Segment focus; Exhibits158: OriGene Technologies Inc. - Overview; Exhibits159: OriGene Technologies Inc. - Product / Service; Exhibits160: OriGene Technologies Inc. - Key offerings; Exhibits161: PerkinElmer Inc - Overview; Exhibits162: PerkinElmer Inc - Business segments; Exhibits163: PerkinElmer Inc - Key news; Exhibits164: PerkinElmer Inc - Key offerings; Exhibits165: PerkinElmer Inc - Segment focus; Exhibits166: Proteintech Group Inc. - Overview; Exhibits167: Proteintech Group Inc. - Product / Service; Exhibits168: Proteintech Group Inc. - Key offerings; Exhibits169: Rockland Immunochemicals Inc. - Overview; Exhibits170: Rockland Immunochemicals Inc. - Product / Service; Exhibits171: Rockland Immunochemicals Inc. - Key offerings; Exhibits172: Santa Cruz Biotechnology Inc. - Overview; Exhibits173: Santa Cruz Biotechnology Inc. - Product / Service; Exhibits174: Santa Cruz Biotechnology Inc. - Key offerings; Exhibits175: Thermo Fisher Scientific Inc. - Overview; Exhibits176: Thermo Fisher Scientific Inc. - Business segments; Exhibits177: Thermo Fisher Scientific Inc. - Key news; Exhibits178: Thermo Fisher Scientific Inc. - Key offerings; Exhibits179: Thermo Fisher Scientific Inc. - Segment focus; Exhibits180: Inclusions checklist; Exhibits181: Exclusions checklist; Exhibits182: Currency conversion rates for US$; Exhibits183: Research methodology; Exhibits184: Validation techniques employed for market sizing; Exhibits185: Information sources; Exhibits186: List of abbreviations